Estimated base case cost and utility outcomes over the lifetime horizon
Treatment . | Costs . | Life-years . | QALYs . | Incremental . | ICER per QALY . | |
---|---|---|---|---|---|---|
Costs . | QALYs . | |||||
Health care sector perspective | ||||||
Liso-cel | $668 624 | 5.34 | 3.64 | $201 001 | 2.02 | $99 669 |
SC | $467 624 | 2.47 | 1.62 | — | — | — |
Societal perspective | ||||||
Liso-cel | $882 475 | 5.34 | 3.64 | $137 560 | 2.02 | $68 212 |
SC | $744 914 | 2.47 | 1.62 | — | — | — |
Treatment . | Costs . | Life-years . | QALYs . | Incremental . | ICER per QALY . | |
---|---|---|---|---|---|---|
Costs . | QALYs . | |||||
Health care sector perspective | ||||||
Liso-cel | $668 624 | 5.34 | 3.64 | $201 001 | 2.02 | $99 669 |
SC | $467 624 | 2.47 | 1.62 | — | — | — |
Societal perspective | ||||||
Liso-cel | $882 475 | 5.34 | 3.64 | $137 560 | 2.02 | $68 212 |
SC | $744 914 | 2.47 | 1.62 | — | — | — |
All costs were adjusted to 2022 USD; values in the table are rounded, which may result in minor discrepancies in summation.
ICER is calculated as incremental costs divided by incremental QALYs.